Market Overview:
The global G-protein coupled receptor (GPCR) targeting market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of various diseases, growing demand for novel therapeutics, and rising investments by pharmaceutical companies in R&D activities. The GPCR targeting market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into consumables and equipment. The consumables segment is further sub-segmented into antibodies, receptors, ligands & probes kits/assays/panels), and other consumables (e.g., buffers). The equipment segment is further sub-segmented into instruments and services. On the basis of application, the market is divided into oncology; cardiovascular system; central nervous system; other applications (respiratory diseases such as asthma & COPD; gastrointestinal diseases such as Crohn’s disease & ulcerative colitis; metabolic disorders such as obesity & diabetes mellitus). Geographically speaking North America dominates this space with around 38% share followed by Europe which has a 31% share in 2017 while Asia Pacific stands third with around 21%.
 Targeting Industry Outlook.svg)
Product Definition:
A G-protein coupled receptor (GPCR) is a type of receptor protein that is activated by binding of a ligand to the receptor. The ligand can be a peptide hormone, neurotransmitter, or other small molecule. When bound to the receptor, the ligand initiates a biochemical cascade that ultimately leads to a cellular response.
GPCRs are important targets for drug development because they are involved in many physiological processes, including regulation of heart rate and blood pressure, digestion and absorption of nutrients, sensation and pain perception, vision and olfaction.
GPCR Consumables:
GPCR Consumables, it's usage.
The global G protein-coupled receptor (GPCR) consumables, it's usage and growth factor in G-protein coupled receptor (GPCR) targeting market size was valued at USD 8.6 million in 2015.
GPCR Equipment:
GPCR targeting is a technique used for the identification of new drug targets by using G protein-coupled receptor (GPCR) as a probe. The main purpose of this procedure is to find out novel compounds that can bind with the extracellular domain of the particular GPCR and hence affect its activity.
Application Insights:
Oncology accounted for the largest revenue share in 2016 owing to the high prevalence of cancer and increasing number of GPCR targeted drugs in pipeline. The oncology segment is also anticipated to register a lucrative CAGR during the forecast period due to an increase in incidence rates of cancer across various parts of world.
The cardiovascular system segment is expected to witness significant growth during the forecast period, as there has been a rise in demand for effective and efficient GPCR targeting therapies that can address unmet needs related to treatment options with fewer side effects. This rise can be attributed primarily towards growing awareness about heart diseases coupled with rising incidences globally. Moreover, several government initiatives are being taken up by countries such as China, India and Australia which aims at reducing mortality rate associated with Cardiovascular Diseases (CVDs). Such favorable factors are expected to drive this application sector over next few years thus driving market growth globally.
Regional Analysis:
North America dominated the global GPCR targeting market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced therapeutics and a large number of GPCR targets. Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing government funding for drug discovery coupled with rising healthcare expenditure in emerging countries such as China and India. Moreover, an increase in awareness about target diseases & treatment options is also anticipated to drive regional growth during the forecast period.
The Asia Pacific region has more than doubled its revenue share from 2016 to 2017 due primarily oncology therapeutic development programs being undertaken by major companies such as Pfizer Inc., Merck KGaA.
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily due to the changing lifestyles and dietary habits of people across the world. According to a study by the World Health Organization (WHO), non-communicable diseases (NCDs) such as heart disease, stroke, cancer, and diabetes accounted for 63% of all deaths worldwide in 2012. This number is expected to rise to 73% by 2030. GPCRs play a key role in the pathogenesis of many chronic diseases and are therefore targeted by several drug developers for the development of novel therapeutics.
- Growing demand for better treatment options: The current treatment options available for many chronic diseases are often inadequate or cause significant side effects. There is therefore a growing demand for better treatment options that can effectively treat these conditions without causing any adverse effects. GPCRs offer great potential as therapeutic targets due to their involvement in several pathological processes involved in various chronic diseases. This has led to increased interest among pharmaceutical companies in developing drugs that target these receptors..
Scope Of The Report
Report Attributes
Report Details
Report Title
G-Protein Coupled Receptor (GPCR) Targeting Market Research Report
By Type
GPCR Consumables, GPCR Equipment
By Application
Oncology, Cardiovascular System, Central Nervous System, Other
By Companies
Thermo Fisher Scientific, PerkinElmer, Merck, BD Biosciences, Molecular Devices, Promega, Qiagen, Abcam, Corning, Cisbio, Discoverx, Enzo Life Sciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
191
Number of Tables & Figures
134
Customization Available
Yes, the report can be customized as per your need.
Global G-Protein Coupled Receptor (GPCR) Targeting Market Report Segments:
The global G-Protein Coupled Receptor (GPCR) Targeting market is segmented on the basis of:
Types
GPCR Consumables, GPCR Equipment
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oncology, Cardiovascular System, Central Nervous System, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific
- PerkinElmer
- Merck
- BD Biosciences
- Molecular Devices
- Promega
- Qiagen
- Abcam
- Corning
- Cisbio
- Discoverx
- Enzo Life Sciences
 Targeting Market Overview.svg)
Highlights of The G-Protein Coupled Receptor (GPCR) Targeting Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- GPCR Consumables
- GPCR Equipment
- By Application:
- Oncology
- Cardiovascular System
- Central Nervous System
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the G-Protein Coupled Receptor (GPCR) Targeting Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Targeting Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
GPCRs are proteins that bind to specific molecules in the body and send signals to cells. GPCR targeting is a process of finding and binding to these receptors so that they can send the appropriate signal. This can be used for a variety of purposes, such as treating diseases or controlling behavior.
Some of the key players operating in the g-protein coupled receptor (gpcr) targeting market are Thermo Fisher Scientific, PerkinElmer, Merck, BD Biosciences, Molecular Devices, Promega, Qiagen, Abcam, Corning, Cisbio, Discoverx, Enzo Life Sciences.
The g-protein coupled receptor (gpcr) targeting market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 G-Protein Coupled Receptor (GPCR) Targeting Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 G-Protein Coupled Receptor (GPCR) Targeting Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 G-Protein Coupled Receptor (GPCR) Targeting Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the G-Protein Coupled Receptor (GPCR) Targeting Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global G-Protein Coupled Receptor (GPCR) Targeting Market Size & Forecast, 2020-2028
4.5.1 G-Protein Coupled Receptor (GPCR) Targeting Market Size and Y-o-Y Growth
4.5.2 G-Protein Coupled Receptor (GPCR) Targeting Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 GPCR Consumables
5.2.2 GPCR Equipment
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Oncology
6.2.2 Cardiovascular System
6.2.3 Central Nervous System
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global G-Protein Coupled Receptor (GPCR) Targeting Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 G-Protein Coupled Receptor (GPCR) Targeting Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 GPCR Consumables
9.6.2 GPCR Equipment
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Oncology
9.10.2 Cardiovascular System
9.10.3 Central Nervous System
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 GPCR Consumables
10.6.2 GPCR Equipment
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Oncology
10.10.2 Cardiovascular System
10.10.3 Central Nervous System
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 GPCR Consumables
11.6.2 GPCR Equipment
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Oncology
11.10.2 Cardiovascular System
11.10.3 Central Nervous System
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 GPCR Consumables
12.6.2 GPCR Equipment
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Oncology
12.10.2 Cardiovascular System
12.10.3 Central Nervous System
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 GPCR Consumables
13.6.2 GPCR Equipment
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Oncology
13.10.2 Cardiovascular System
13.10.3 Central Nervous System
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 G-Protein Coupled Receptor (GPCR) Targeting Market: Competitive Dashboard
14.2 Global G-Protein Coupled Receptor (GPCR) Targeting Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher Scientific
14.3.2 PerkinElmer
14.3.3 Merck
14.3.4 BD Biosciences
14.3.5 Molecular Devices
14.3.6 Promega
14.3.7 Qiagen
14.3.8 Abcam
14.3.9 Corning
14.3.10 Cisbio
14.3.11 Discoverx
14.3.12 Enzo Life Sciences
